Nuvectis Pharma Ownership | Who Owns Nuvectis Pharma?
Nuvectis Pharma Ownership Summary
Nuvectis Pharma is owned by 6.09% institutional investors, 51.52% insiders, and 42.39% retail investors. Vanguard group is the largest institutional shareholder, holding 1.52% of NVCT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.22% of its assets in Nuvectis Pharma shares.
NVCT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nuvectis Pharma | 6.09% | 51.52% | 42.39% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 251.14K | 1.52% | $1.59M |
| Baldwin brothers llc/ma | 168.63K | 1.02% | $1.07M |
| Millennium management | 119.46K | 0.72% | $756.17K |
| Blackrock | 83.41K | 0.50% | $528.00K |
| Renaissance | 74.50K | 0.45% | $471.58K |
| Goldman sachs group | 61.57K | 0.37% | $389.74K |
| Geode capital management | 53.23K | 0.32% | $337.00K |
| Northern trust | 49.83K | 0.30% | $315.40K |
| Gsa capital partners llp | 48.34K | 0.29% | $306.00K |
| Forbes j m & co llp | 47.42K | 0.29% | $300.16K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Baldwin brothers llc/ma | 168.63K | 0.08% | $1.07M |
| Forbes j m & co llp | 47.42K | 0.03% | $300.16K |
| Gsa capital partners llp | 48.34K | 0.02% | $306.00K |
| Baxter bros | 12.50K | 0.01% | $79.13K |
| Edmond de rothschild | 19.17K | 0.00% | $121.35K |
| Renaissance | 74.50K | 0.00% | $471.58K |
| Tower research capital llc (trc) | 6.00K | 0.00% | $37.95K |
| Millennium management | 119.46K | 0.00% | $756.17K |
| Marshall wace, llp | 33.87K | 0.00% | $214.38K |
| Two sigma investments, lp | 13.04K | 0.00% | $82.57K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 119.46K | 0.00% | 79.96K |
| Goldman sachs group | 61.57K | 0.00% | 61.57K |
| Citadel advisors | 14.94K | - | 14.94K |
| Baldwin brothers llc/ma | 168.63K | 0.08% | 14.50K |
| Forbes j m & co llp | 47.42K | 0.03% | 13.42K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 83.41K | - | -289.31K |
| State street | 15.30K | - | -114.08K |
| Geode capital management | 53.23K | - | -81.30K |
| Vanguard group | 251.14K | - | -47.66K |
| Morgan stanley | 10.20K | - | -30.99K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Goldman sachs group | 61.57K | 0.00% | 61.57K | $389.74K |
| Citadel advisors | 14.94K | - | 14.94K | $94.55K |
| Baxter bros | 12.50K | 0.01% | 12.50K | $79.13K |
| Qube research | 7.98K | 0.00% | 7.98K | $50.50K |
| Macquarie group | 355.00 | - | 355.00 | $2.25K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -1.00 |
| Gamma investing | -25.00 |
| Amalgamated bank | -231.00 |
| Royal bank of canada | -270.00 |
| Trust co of vermont | -500.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 31 | -18.42% | 1,049,389 | -12.85% | 6 | 11.52% | 14 | -44.00% | 11 | - |
| Jun 30, 2024 | 38 | -5.00% | 1,204,111 | -22.91% | 7 | 9.04% | 25 | 13.64% | 11 | - |
| Mar 31, 2024 | 40 | 11.11% | 1,561,981 | 3.22% | 8 | 10.16% | 22 | 4.76% | 11 | 83.33% |
| Dec 31, 2023 | 36 | 9.09% | 1,513,319 | 18.48% | 9 | 13.27% | 21 | 40.00% | 6 | -53.85% |
| Sep 30, 2023 | 33 | -10.81% | 1,277,304 | 1.95% | 8 | 11.62% | 15 | -57.14% | 13 | 550.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 231.04K | 1.22% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 57.03K | 0.30% | - |
| Fidelity Extended Market Index | 38.70K | 0.21% | 11.17K |
| iShares Micro-Cap ETF | 21.22K | 0.11% | - |
| NT R2000 Growth Index Fund - NL | 20.57K | 0.11% | - |
| NT R2000 Index Fund - NL | 13.99K | 0.07% | -5.76K |
| Fidelity Total Market Index | 13.36K | 0.07% | 8.99K |
| The Vanguard Russell 2000 Growth Index | 12.03K | 0.06% | - |
| NT R2000 Growth Index Fund - L | 11.40K | 0.06% | -3.64K |
| Northern Trust Russell 2000 Growth Index | 11.40K | 0.06% | -3.64K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 12, 2024 | Mosseri Marlio Charles | - | Buy | $149.04K |
| Dec 13, 2024 | Mosseri Marlio Charles | - | Buy | $79.90K |
| Dec 13, 2024 | Mosseri Marlio Charles | - | Buy | $79.90K |
| Nov 19, 2024 | Poradosu Enrique | Chief Science & Business Off | Buy | $9.98K |
| Nov 15, 2024 | BENTSUR RON | Chairman & CEO | Buy | $98.40K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 2 | 1 |
| 2024 Q3 | - | - |
| 2024 Q2 | 4 | - |
| 2024 Q1 | 1 | - |
| 2023 Q4 | 5 | - |
NVCT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools